Brukinsa Zanubrutinib — Highmark
8 indications indexed for this drug.
- Any Covered Indication For A Btk InhibitorView coverage criteria
- Chronic Lymphocytic Leukemia CllView coverage criteria
- Follicular Lymphoma FlView coverage criteria
- Mantle Cell Lymphoma MclView coverage criteria
- Marginal Zone Lymphoma MzlView coverage criteria
- Quantity Limit ExceptionView coverage criteria
- Small Lymphocytic Lymphoma SllView coverage criteria
- Waldenstr M S Macroglobulinemia WmView coverage criteria